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a b s t r a c t
Thrombophilia stands for a genetic or an acquired tendency to hypercoagulable states that increase the
risk of venous and arterial thromboses. Indeed, venous thromboembolism is often a chronic illness,
mainly in deep venous thrombosis and pulmonary embolism, requiring lifelong prevention strategies.
Therefore, it is crucial to identify the cause of the disease, the most appropriate treatment, the length
of treatment or prevent a thrombotic recurrence. Thus, this work will focus on the development of a diag-
nosis decision support system in terms of a formal agenda built on a logic programming approach to
knowledge representation and reasoning, complemented with a case-based approach to computing.
The proposed model has been quite accurate in the assessment of thrombophilia predisposition risk,
since the overall accuracy is higher than 90% and sensitivity ranging in the interval [86.5%, 88.1%]. The
main strength of the proposed solution is the ability to deal explicitly with incomplete, unknown, or even
self-contradictory information.
 2016 Elsevier Inc. All rights reserved.
1. Introduction
Thrombophilia described genetic or acquired tendency to
hypercoagulable states that increase the risk of venous thrombosis
and, in some cases arterial thrombosis [1]. Venous ThromboEmbo-
lism (VTE) is the most common vascular disease after acute
myocardial infarction and stroke. It is represented by two main
clinical events: Deep Venous Thrombosis (DVT) and Pulmonary
Embolism (PE), which often constitute a unique clinical picture in
which PE follows DVT [2]. Primary hypercoagulable states are gen-
erally inherited abnormalities of coagulation such as antithrombin
III deficiency, protein C and protein S deficiency. High risk throm-
bophilia includes natural coagulation inhibitors (antithrombin
deficiency, protein C deficiency, protein S deficiency and homozy-
gosity for factor V Leiden or the prothrombin G20210A gene muta-
tion, compound heterozygosity for factor V Leiden and the
prothrombin gene mutation) [3,4]. Secondary hypercoagulable
states are frequently acquired disorders in patients with underly-
ing systemic diseases or clinical conditions, known to be associated
with an increased risk of thrombosis (e.g., malignancy, pregnancy,
use of oral contraceptives, myeloproliferative disorders, hyperlipi-
demia, diabetes mellitus and abnormalities of blood vessels). The
most common acquired thrombophilia is antiphospholipid anti-
body syndrome [5]. Furthermore, the long distance travel is often
associated with an up to 4-fold increased risk of VTE compared
to non-travelers [6]. Air pollution was also associated to the hyper-
coagulable states in patients with DVT [7].
The incidence of VTE is estimated at 56–160/100.000 people/year
[8], and strongly age-dependent, rising nearly 1% per year in old age
[9]. Studies showthat about70%of patientspresentingafirst episode
ofVTEareover60 yearsold, and the rateof recurrence ishigherwhen
the first episode of VTE occurs before 60 years old [10]. Patientswith
VTE have laboratorial abnormalities and clinical conditions that are
associated with an increased risk of thrombosis (prethrombotic
states) or have recurrent thrombosis without recognizable predis-
posing factors (thrombosis-prone). The stated above highlights
how it is important to assess the patient’s clinical probability for
VTE. In this context, the Wells score has been commonly used,
namely in patients with suspected DVT or PE [11]. Based on Wells
score thephysician canorder theD-dimer test as amarkerof endoge-
nous fibrinolysis [11]. Follow-up of patients for prolonged periods
after an initial DVT or PE has revealed a startling fact, i.e., VTE often
is a chronic illness requiring lifelong prevention strategies. Thus, it
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